Sven Davisson was named associate director of administration at Louisiana Cancer Research Center.
Moffitt Cancer Center, Weill Cornell Medicine, and the University of North Carolina School of Medicine received a $3.5 million, five-year grant from NCI to improve screening and preventative treatment of cervical cancer for women living with HIV in low-resource countries.
The International Cardio-Oncology Society has awarded University Hospitals Harrington Heart & Vascular Institute a Center of Excellence designation in recognition of its ongoing support of cancer patients facing heart issues. This Gold Status certification, the society’s highest designation, recognizes the institute for its commitment to cardiology services for cancer patients in whom life-saving treatments may cause cardiac problems.
Jeffrey Holzbeierlein, the William L. Valk endowed professor and chair of urology at the University of Kansas Medical Center, was named physician in chief of The University of Kansas Cancer Center.
Richard D. Carvajal, a clinician and researcher in melanoma and early phase drug development, was named deputy physician-in-chief and director of medical oncology at the Northwell Health Cancer Institute.
Travis Poole was named associate director of research administration at MUSC Hollings Cancer Center.
University of Pittsburgh received a five-year, $11.2 million SPORE to support the Head and Neck Cancer Specialized Program of Research Excellence at UPMC Hillman Cancer Center. This is one of two SPOREs awarded to Pitt/Hillman and one of 11 SPORES supported by NIH in 2022.
Jason Luke was named interim associate director for clinical research at UPMC Hillman Cancer Center.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Emory University will share a five-year, $3.3 million NIH grant to study spectroscopic MRI and make it easier to use.
Pedro Torres-Ayuso, an assistant professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, received a $50,000 grant through the SPORE Career Enhancement Program.
